The best indicator for Bristol Myers Squibb (BMY)
We backtested 382 indicators across daily, weekly and hourly charts on real Bristol Myers Squibb (BMY) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
QQE
On the weekly chart, this is the strongest risk-adjusted edge we found for Bristol Myers Squibb (BMY) over ~54.2 years — beating buy-and-hold by 0.8% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Bristol Myers Squibb (BMY) — trailing buy-and-hold by 4.0% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | QQE ✓ | Weekly | 11.0% | 0.55 | -56.3% | 47.9% | 163 | 0.8% |
| 2 | Volume Flow Indicator ✓ | Weekly | 9.6% | 0.55 | -51.3% | 46.7% | 15 | -0.6% |
| 3 | DEMA 200 Trend ✓ | Weekly | 8.1% | 0.55 | -42.5% | 48.9% | 47 | -2.1% |
| 4 | Trendlines with Breaks ✓ | Weekly | 9.1% | 0.55 | -51.1% | 54.5% | 22 | -1.2% |
| 5 | SMC: Change of Character ✓ | Weekly | 9.4% | 0.54 | -51.6% | 57.1% | 21 | -0.9% |
| 6 | Ichimoku Cloud ✓ | Weekly | 8.3% | 0.53 | -56.1% | 39.7% | 58 | -2.0% |
| 7 | Positive Volume Index ✓ | Weekly | 7.8% | 0.53 | -53.8% | 38.1% | 21 | -2.4% |
| 8 | EMA 10/40 Cross ✓ | Weekly | 8.8% | 0.53 | -57.6% | 41.9% | 31 | -1.5% |
| 9 | WMA 100 Trend ✓ | Weekly | 8.2% | 0.52 | -67.5% | 39.2% | 51 | -2.0% |
| 10 | TRIX (21) ✓ | Weekly | 8.5% | 0.52 | -59.1% | 52.9% | 17 | -1.8% |
| 11 | G-Channel ✓ | Weekly | 8.4% | 0.52 | -59.0% | 44.1% | 59 | -1.8% |
| 12 | EMA 50/200 Cross ✓ | Daily | 8.6% | 0.51 | -62.0% | 36.7% | 30 | -1.8% |
| 13 | McGinley 200 Trend ✓ | Daily | 10.3% | 0.51 | -70.6% | 21.1% | 19 | -0.1% |
| 14 | EMA 20/50 Cross ✓ | Weekly | 8.2% | 0.51 | -62.5% | 47.6% | 21 | -2.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Bristol Myers Squibb (BMY), QQE on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when Bristol Myers Squibb’s signal flips
We track Bristol Myers Squibb daily. Its backtested best indicator, QQE (Weekly), is long right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.